• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体成分C1、C4和C2对淋巴细胞对有丝分裂原和抗原的增殖反应的调节作用。

Modulation of lymphocyte proliferative responses to mitogens and antigens by complement components C1, C4 and C2.

作者信息

Laham M N, Caldwell J R, Panush R S

出版信息

J Clin Lab Immunol. 1982 Oct;9(1):39-47.

PMID:6983586
Abstract

Recent data have shown a definite relationship between complement and lymphocytes. Genetic studies have demonstrated close linkage between the genes controlling synthesis of complement components C4 and C2 and the major histocompatibility complex. Working in a complement-free environment, we studied the effect of purified human complement components, individually and in various combinations, upon in vitro proliferative responses of human lymphocytes to mitogens and antigens. It was found that the early complement components C1, C4 and C2, together, modulate lymphocyte responses to these various stimuli. In general, doses up to 1,000 effective molecules of each component per lymphocyte enhanced the cells' responses to both mitogens and antigens. Higher doses, up to 3,000 effective molecules of each per lymphocyte, progressively inhibited the cells' responses to the mitogens whereas responses to the antigens showed continued enhancement. This effect was removed by prior heat-inactivation of the complement. It persisted when the cells were exposed to C1, C4 and C2 for 1 hr, then washed and cultured with mitogen. It required active C1 in the fluid-phase prior to addition of C4 and C2. It correlated with the amount of activated C2 to which the cells were exposed. Enriched populations of T and B cells were affected equally.

摘要

最近的数据显示补体与淋巴细胞之间存在明确的关系。遗传学研究表明,控制补体成分C4和C2合成的基因与主要组织相容性复合体之间存在紧密的连锁关系。在无补体的环境中,我们研究了纯化的人补体成分单独及各种组合对人淋巴细胞体外对有丝分裂原和抗原的增殖反应的影响。发现早期补体成分C1、C4和C2共同调节淋巴细胞对这些不同刺激的反应。一般来说,每个淋巴细胞高达1000个有效分子的剂量可增强细胞对有丝分裂原和抗原的反应。更高的剂量,即每个淋巴细胞高达3000个有效分子,会逐渐抑制细胞对有丝分裂原的反应,而对抗原的反应则持续增强。这种效应可通过补体预先热灭活消除。当细胞暴露于C1、C4和C2 1小时,然后洗涤并用有丝分裂原培养时,这种效应仍然存在。在添加C4和C2之前,液相中需要有活性的C1。它与细胞暴露的活化C2量相关。T细胞和B细胞的富集群体受到的影响相同。

相似文献

1
Modulation of lymphocyte proliferative responses to mitogens and antigens by complement components C1, C4 and C2.补体成分C1、C4和C2对淋巴细胞对有丝分裂原和抗原的增殖反应的调节作用。
J Clin Lab Immunol. 1982 Oct;9(1):39-47.
2
Modulation of monocyte complement synthesis by lymphocytes and lymphocyte-conditioned media.淋巴细胞及淋巴细胞条件培养基对单核细胞补体合成的调节作用。
Clin Exp Immunol. 1989 Apr;76(1):86-91.
3
Prevention of immune precipitation by purified classical pathway complement components.利用纯化的经典途径补体成分预防免疫沉淀。
Clin Exp Immunol. 1984 Nov;58(2):486-92.
4
Hemolytic efficiency of cell-bound IgM: evidence that IgM-C1 complexes activate C4 molecules not hemolytic with homologous C2--C9.细胞结合型IgM的溶血效率:IgM-C1复合物激活不能与同源C2-C9发生溶血反应的C4分子的证据。
J Immunol. 1982 Apr;128(4):1600-2.
5
Inhibition of activation of human T lymphocytes by the complement C1 esterase inhibitor.补体C1酯酶抑制剂对人T淋巴细胞活化的抑制作用。
Immunology. 1995 Oct;86(2):304-10.
6
Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor.阐明凝集素补体途径中MASP-2蛋白酶的底物特异性,并鉴定该酶为丝氨酸蛋白酶抑制剂C1抑制剂的主要生理靶点。
Mol Immunol. 2008 Feb;45(3):670-7. doi: 10.1016/j.molimm.2007.07.008. Epub 2007 Aug 20.
7
The C4 and C2 but not C1 components of complement are responsible for the complement activation triggered by the Ra-reactive factor.补体的C4和C2成分而非C1成分负责由Ra反应因子触发的补体激活。
J Immunol. 1988 Dec 15;141(12):4271-5.
8
Relationship of functional levels of early components of complement to the H-2 complex of mice.小鼠补体早期成分功能水平与H-2复合体的关系。
J Immunol. 1976 Nov;117(5 Pt 1):1584-8.
9
B- and T-cell markers on human lymphoblasts after stimulation with mitogen or antigens.用有丝分裂原或抗原刺激后人淋巴母细胞上的B细胞和T细胞标志物。
Clin Exp Immunol. 1975 Oct;22(1):121-5.
10
[B, C2 and C4 complement factors, the HLA system and diseases. Genetic relation].[B、C2和C4补体因子、HLA系统与疾病。遗传关系]
Pathol Biol (Paris). 1983 Sep;31(7):622-30.

引用本文的文献

1
Modulation of human mononuclear cell responses by neutrophil-derived factors. II. Partial characterization of a neutrophil-derived lymphocyte-enhancing factor (N-LEF).中性粒细胞衍生因子对人单核细胞反应的调节。II. 中性粒细胞衍生的淋巴细胞增强因子(N-LEF)的部分特性
Inflammation. 1983 Mar;7(1):35-47. doi: 10.1007/BF00918006.
2
Infectious diseases associated with complement deficiencies.与补体缺陷相关的传染病。
Clin Microbiol Rev. 1991 Jul;4(3):359-95. doi: 10.1128/CMR.4.3.359.